Bao et al. reported that the novel Nrf2 target gene, ABCF2, plays a critical role in cisplatin resistance in ovarian cancer, and targeting Nrf2 signaling may be a potential strategy to improve chemotherapeutic efficiency in ovarian cancer [27]. Here, ABCF2 is linked to ovarian cancer.